Tuesday, 14th November Clinical Oncology Society of Australia Annual Scientific Meeting 2017

Chair: Prof Stephen Clarke
Speakers: 
Dr Adnan Nagrial, Crown Princess Mary Cancer Centre Westmead - "Managing patients with non-mutation 2nd line NSCLC"
Dr Steven Kao, Chris O'Brien Lifehouse - "2nd line ALK and NSCLC - approach to targeted therapies" 

Speakers: Tim Hucker & Paul Glare

This symposium will be an update on the current management of cancer pain, exploring the current basis of treatment and its limitations and discussing alternative management options in common practice in the U.S.A and Europe. The first session by Professor Paul Glare will discuss Opiate medication, its development as the mainstay of cancer pain management and the W.H.O model. Despite this development, opioids have limited efficacy and the model of cancer pain management has not changed despite the enormous progress seen in oncology treatment. Furthermore, with oncological advances the profile of the patient during or post cancer treatment specifically has changed drastically in the lifespan of the W.H.O model. Additionally, the landscape of opiate misuse has changed drastically with Australia experiencing an “opioid epidemic”. Chronic non-cancer pain management has altered in this time to carefully protocolised opioid therapy. Cancer pain management is still considered as a separate entity to non-cancer pain management, however, considerable overlap exists with the oncology patient experiencing multiple non oncological morbidities. Many further similarities exist between these populations and therefore chronic non-cancer pain management can be adapted to provide multidisciplinary, efficacious and non opioid based pain solutions in patients with cancer. The second session from Dr Tim Hucker will discuss non opioid medication and interventional options for cancer pain management. europathic pain is prevalent in cancer, either from the cancer itself or its treatment and throughout the cancer journey. Even in survivorship, neuropathic pain is common and persistent. The limitation of efficacy in opiate management of neuropathic pain will be highlighted. Despite being part of cancer pain management guidelines and contrary to other countries, interventional pain options are infrequently considered. There are a wide variety of pain syndromes in the cancer patient and interventional options exist in many situations. The careful application of interventional techniques in this population will aid efficacy and also assist in limiting opiate related side effects and wider opiate burden.

This breakfast session is supported by Medtronic

• Lung cancer patient selection (clinical biomarkers) - Matthew D. Hellmann
• Predicating response and resistance in drug therapy for advanced melanoma - Georgina Long
• Predictive markers of response and resistance to immunotherapies - Richard Scolyer
• Treating non-trial populations   - Alexander Menzies

10:20 AM Panel Discussion

• Beyond PD1's emerging therapies - Matteo Carlino
• New indications in GU cancers - Craig Gedye
• Update on current lung cancer trials - Ben Solomon
• Compassionate Access and Cost Share Programs: The Pharmacy Perspective - Graham Rivers

• Clinical Trial Activity in Victoria: Cancer Trials Management Scheme Data, 2009 to 2015. - Christie Allan
• The Improving Rural Cancer Outcomes (IRCO) Trial: a factorial cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia. - Jon Emery
• Informing women about overdetection in breast cancer screening: Randomised controlled trial with 2-year follow-up - Jolyn Hersch
• Hospital lung surgery volume and patient outcomes in Victoria - Paul Mitchell
• Improving patient access to novel cancer drugs in Australia: are we there yet? - Haitham Tuffaha
• Testing wisely: when is both HER2 immunohistochemistry and in-situ hybridisation really necessary? - Adithya Balasubramanian

• One size doesn’t fit all: Responders and non-responders to exercise interventions for cancer patients and survivors - Prue Cormie
• Is it feasible to delivery an online psycho-sexual intervention (Rekindle) to Australian cancer survivors and their partners: a randomised phase II feasibility study - Haryana M Dhillon
• Do childhood cancer survivors achieve recommended physical activity levels? A report from the ANZCHOG Survivorship Study - David Mizrahi
• A randomized controlled trial of an advance care planning intervention for patients with incurable cancer - Martin Tattersall
• Financial toxicity, employment and quality of life of cancer survivors. A secondary analysis of the PROFILES registry. - Bianca Tomalin

• Nurses role in the assessment and management of patients on I-O drugs - Donna Milne
• Models of Care for Immunotherapy Patients - Rob Zielinski
• Safe delivery of immunotherapy: A private cancer physician’s perspective - Christopher Steer
• Models of care for immunotherapy patients: Palliative care perspective - Katherine Clark

• Systematic approaches to reduce time to implementation - Nicole Rankin
• Moffitt clinical pathways: translating evidence into standardized practice - Dana Rollison
• The role of inspiration, perspiration and evidence in research translation - Christine Paul
• A framework for de-intensification of cancer screening programs - Alexandra Barratt

This sessions follows a highly successful format used at previous meetings. It is designed to provide a forum for discussion of the complex issues which arise in the care of patients undergoing immunotherapy treatment. The facilitators will present a series of challenging clinical cases and engage members of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience to contribute to the discussion. Panellists will include a medical oncologist, radiation oncologist, surgeon, palliative care physician, nurse, psycho-oncologist and consumer.

• Anti-cancer drug administration nursing competency audit - Spiridoula Galetakis
• Evaluation of referral patterns for newly diagnosed breast cancer to the familial cancer centre - Prachi Bhave
• Factors associated with electrolyte imbalances in terminally ill patients. - Pawel Bryniarski
• An audit of timely access to evidence-based pathways of cancer care for patients with thoracic malignancies in Australian Capital Territory (ACT) Region. - Sabeeh Butt
• Antiresorptive therapy in metastatic breast cancer – A retrospective audit - Robert Campbell
• Identifying and examining quality indicators in lung cancer - Kim-Lin Chiew
• Use of Vena Caval Filters in Management of Venous Thromboembolism - a single centre experience - Timothy Clay
• Principles for best practice lung cancer care in Australia: Implementation of evidence-based Principles to improve outcomes - Barbara Daveson
• Complications associated with Peripherally-inserted central catheters (PICCs) and totally implanted venous access ports (TIVAPs) in oncology patients the Royal Darwin Hospital in 2015 - George Drewett
• Medical Emergency Team (MET) calls in patients with metastatic disease – is there a benefit? - Grace Gard
• Consensus Resuscitation Plan documentation in patients with metastatic cancer – where are we and how can we improve? - Grace Gard
• A new comprehensive head and neck cancer service at St Vincent’s Hospital Melbourne: assessment of the first twelve months - Keri-Lee Geneser
• Retrospective audit of Capecitabine dosing, safety and tolerability in patients aged ≥ 70 years old with gastrointestinal cancer in a tertiary cancer centre - Sharon Heng
• Monitoring variations in chemotherapy prescribing practices in South Western Sydney local health district - Nasreen Kaadan
• Planning for quality and safety in regional cancer services - Tom Keating
• Patient-reported outcomes, experiences and needs of lesbian, gay and bisexual survivors of cancer: a mixed-method study - Karolina Lisy
• Facilitating clinician-led, statewide governance for cancer chemotherapy in Queensland. - Thomas G Mackay
• Preparing for pathway implementation: a study of awareness and use of Optimal Cancer Care Pathways in Queensland in February 2017. - Peter McGuire
• The role of smoking cessation in clinical oncology: Australian oncologists’ experiences, preferences and practices. - Christine Paul
• Establishing clinical quality indicators for lung cancer care in the Barwon South West Region:  Outcomes from 2009 to 2014 - Graham Pitson
• Implementing Optimal Care Pathways: A "Deed of Partners" - Marita Reed
• Can the centralised preparation of monoclonal antibodies save money? - Jim Siderov
• Can care for lung cancer patients across regional public and private health services be mapped against Optimal Care Pathways? - Ilana Solo
• Chemotherapy-induced peripheral neuropathy – patient reported outcomes compared with clinician and nursing assessment - Aaron C Tan
• Knowledge and comprehension of advance care planning in people with cancer - Anna Ugalde
• A case study: Successful administration of chemotherapy using an arteriovenous fistula device in haemodialysis patient with a new diagnosis of lung cancer. - May Valdez
• A retrospective audit assessing the quality of care regarding timeline of initial management for lung cancer patients referred to a tertiary hospital - Mitchell S von Itzstein
• Surveillance colonoscopy after curative resection of colorectal cancer - A retrospective audit of institutional compliance - Wing Hing Yau
• Head and neck cancers audit of chemoradiotherapy at Monash Cancer Centre - Penny Walker
• Linking patients with cancer clinical trials: improving the accessibility of the Victorian Cancer Trials Link website. - Christie Allan
• Improved Clinical Documentation for Improved Communication - Shoma Ms Barat
• Putting numbers to the faces: quantifying the need for allied health practitioners in a rural cancer centre - Jorja Braden
• Queensland Youth Cancer Service: a partnership model to facilitate access to quality care for young people diagnosed with cancer - Natalie Bradford
• Does timeliness of care in non-small cell lung cancer impact on survival? - Amrita Chandra
• Compassionate Supply of Oncology Drugs within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015 - Timothy TC Chin
• A single centre experience of malignant pleural mesothelioma over a five year period - Timothy D Clay
• Salvage Stereotactic Radiosurgery for recurrent high-grade glioma with prior Radiotherapy   - Mary Costantini
• Developing a geriatric oncology service in Australian capital territory based on a model, with cancer social worker co-ordination. - Divyanshu Dua
• Audit of chemotherapy dose reduction in curative intent breast and colorectal cancer patients - Ibrahim Fleyfel
• Criterion-based benchmarking (CBB) approach of the appropriate use of radiotherapy in NSW-ACT, Australia - Gabriel Gabriel
• An integrated and collaborative approach: Improving the quality of colonoscopy referrals by providing GPs with specific and accurate feedback - Carol Gibbins
• Safety and viability of immunotherapy delivery at a regional Queensland centre - Ben Gunawan
• The role of surgery in colorectal cancer treatment defined by a benchmark rate of optimal surgical utilisation - Susannah A Jacob
• Use of optimal cancer care pathway in breast cancer : A systematic review of literature. - Abhishek Joshi
• Optimal cancer care pathway in breast cancer diagnosis and surveillance: A qualitative study of health care provider perspectives in North Queensland. - Abhishek Joshi
• How well are co-morbidities managed in cancer? Results of a national survey of breast cancer survivors. - Bogda Koczwara
• Payer acceptability of metastasis-free survival as the primary endpoint in non-metastatic castration-resistant prostate cancer - Laurence Krieger
• An integrative oncology service in the Australian healthcare setting – The Chris O’Brien Lifehouse Comprehensive Cancer Centre experience - Judith Lacey
• Victorian lung cancer service redesign projects diagnostic phase challenges and learnings - Geraldine Largey
• Outcomes of a national pilot program to adopt the Optimal Cancer Care Pathways (OCPs) into cancer services. - Phillipa Lowrey
• Pulmonary rehabilitation and eHealth practices for patients undergoing surgical treatment for lung cancer – A survey of MDT sites around Australia - Michael Marthick
• Barriers and enablers to accessing clinical trials in a non-metropolitan region - Sally McCarthy
• Mainstreaming Exercise into Cancer Care: Adherence to and outcomes of a prescribed exercise program “Active Survivor” for patients with solid cancers. - Sayeda K Naher
• Hide and seek with hereditary cancer- Evaluating a theory grounded approach to implementing systems change to appropriately detect and refer Lynch Syndrome patients - Sundresan Naicker
• Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit - Christine Paul
• Does comorbid anxiety lead to increased health resource use or costs among cancer patients? A review of current evidence - Alison Pearce
• When guidelines don’t guide: Increasing applicability for guidelines for CRF - Elizabeth Pearson
• Ask the audience: Overcoming consumer barriers to managing cancer-related fatigue - Elizabeth J Pearson
• The Impact of a Breast Cancer Diagnosis on Women’s Work Status - Meron Pitcher
• Caregivers' perception of psychosocial issues of pediatric osteosarcoma patients: An exploratory study - Chindhu Shunmugasundaram
• Exercise oncology: More than just sets and reps - Tina L. Skinner
• A neighborhood houses community transport project - Ilana Solo
• Implementation of an immuno-oncology cancer nurse coordinator role in a tertiary hospital:  Six month evaluation - Helen Westman
• Cancer care coordinators in Victoria: role and scope of practice - Anna Ugalde
• Reliability of patient-led screening with the Malnutrition Screening Tool (MST):  agreement between patient and health professional scores in the cancer care ambulatory setting - Teresa Brown
• Comparing outcomes between SWOG Cisplatin and Etoposide  and low dose weekly Cisplatin  and Docetaxel chemotherapy protocols for concurrent chemo-irradiation in non-small cell lung cancer (NSCLC). - Yolande Cox
• Implementation of Remote Pharmacist Verification of Cancer Medicine Prescriptions within a Day Oncology Hospital - Courtney King
• Improvement of a clinical pharmacy service in the absence of an onsite pharmacy within a metropolitan day oncology hospital - Neil Lam
• An Audit of Outpatient Medical Oncology Care of Regional, Rural and remote patients in a metropolitan Medical Oncology Cancer Centre - Christine Henneker
• CMV retinitis from good syndrome in thymic carcinoma - Chris Lomma
• Hospital In the home for mater cancer care patients - Paul Moran
• Evaluating the use of online chat for the provision of cancer information and support. - Amanda Robertson
• Addressing unmet needs in the provision of cancer information and support: Implementation of a call back service. - Amanda Robertson
• Gippsland Cancer Survivorship Project: Improving care and co-ordination of regional cancer services between primary and specialist health providers - Danielle Roscoe
• Starting from scratch - how to set up an oncology pharmacy service. - Bharti Tailor
• Chemotherapy information in paediatric oncology: What do families want? - Hayley Vasileff
• Register4: Fast tracking recruitment for cancer research projects - Prue Weideman
• A tailored service model to improve timely delivery of immunotherapies pembrolizumab and nivolumab - Samantha Wieringa
• Closing the Gap in Oncology: From principles to practice with the National Aboriginal and Torres Strait Islander Cancer Framework - Sophia Wooldridge
• Investigating the impact of physical activity on cognition-related quality of life in younger women after breast cancer treatment - Melissa Arneil
• Utilising digital innovation to empower people affected by cancer - Annette Beattie
• From Clinical Trial to Open Access: the evolution and implementation of Finding My Way into a community cancer resource. - Lisa Beatty
• Tube feeding duration in head and neck cancer patients undergoing radiotherapy +/- chemotherapy - Katherine Bell
• Psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study - Lucy Braude
• The thing about cancer podcast series – an innovative way to deliver information to people affected by cancer - Jenni Bruce
• Predictors and consequences of lack of proper hydration in patients of Palliative Care Unit. - Pawel Bryniarski
• Long term outcomes of prophylactic orthopaedic intervention for patients with skeletal metastases - Nikki Burdett
• Demographics of 100 consecutive patients with newly diagnosed thoracic malignancies discussed in the Multidisciplinary Meetings (MDMs) in Australian Capital Territory (ACT) Region. - Sabeeh Butt
• Yarning About Cancer: Training support group leaders in Aboriginal and Torres Strait Islander communities   - Sally Carveth
• Communicating with children about (neo)adjuvant chemotherapy for early breast cancer: experiences of women in South Western Sydney.  - Hannah M Corbett
• Exercise medicine for brain cancer: Safety and feasibility of supervised exercise during adjuvant treatment of high-grade glioma - Prue Cormie
• Online educational initiative to address the clinical challenges of chemotherapy-induced nausea and vomiting (CINV) - Keith Cox
• A stepped-care cognitive behavioural intervention for insomnia in cancer survivors - Justine Diggens
• Acupuncture and reflexology service for patients in the day therapy unit for chemotherapy in a large comprehensive cancer centre. A pilot study - Suzanne J Grant
• Supportive Care and Integrative Oncology: Barriers and Unmet Needs - Suzanne J Grant
• Participating in exercise during chemoradiotherapy helps patients diagnosed with High Grade Glioma to feel stronger and actively involved in their fight against cancer: a qualitative study - Prue Cormie
• The relationship between supportive care needs and perceived burden among breast cancer survivors and their caregivers. - Emma Kemp
• Prescribing medicinal cannabis for chemotherapy induced nausea and vomiting and refractory advanced cancer related symptoms: A prescribing physician's perspective  - Judith Lacey
• “Talking woman to woman”: Peer-patient discussions about psychosexual issues and vaginal dilators following radiotherapy for gynaecological cancer within the PeNTAGOn trial - Ilona Juraskova
• Improving health literacy in cancer survivors and carers; developing & measuring outcomes from a small group education intervention. - Donna Lever
• A cross-sectional survey: assessment of long term alopecia after adjuvant taxane therapy fro early breast cancer. - Jennifer W Lim
• Effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese lung cancer patients - Kate White
• ENRICHing Survivorship – empowering cancer survivors through education about exercise, nutrition and mindset utilising an evidence-based program in collaboration with allied health professionals. - Lauren McClean
• Feasibility and preliminary efficacy of a six-week exercise intervention in patients with malignant pleural disease. - Carolyn J McIntyre
• Communicating with consumers about immunotherapy: balancing reality with hope - Jenny Mothoneos
• Accessible cancer information for consumers – designing a cancer information and resource lounge - Angela Murray
• Quantifying intervention engagement in a trial of online versus telephone-based information and support for new lung cancer patients - Christine Paul
• Impacts on employment, finances and lifestyle for working age people facing an expected premature death: A systematic review - Jane L Phillips
• Cancer pain management needs and perspectives of patients from Chinese backgrounds: A systematic review of the Chinese and English literature - Jane L. Phillips
• Service Evaluation of the First Psycho-Oncology Outpatient Service in Regional Victoria - Nagusha Rachagan
• Medicinal Cannabis and Cancer: A Narrative Systematic Literature Review - Janet Schloss
• ‘A common path: cancer information and advice’. Production of patient information videos - Melissa Shand
• A sustainable, holistic cancer specific rehabilitation program in an underserved area - Ilana Solo
• Increasing awareness of the supportive care screening tool among allied health staff at a sub-regional health service - Ilana Solo
• Physical activity during cancer treatment: A survey of what Australian Cancer Health Professionals think - Jane Turner
• Development and validation of the terminal delirium scale, a scale for assessment of irreversible terminal delirium - Megumi Uchida
• Physical activity for women with metastatic breast cancer: a pilot RCT - Jasmine Yee
• Mindfulness, acceptance and meaning in life for adults with cancer   - Fernanda Zimmermann
• TelePalliative care in regional Western Australia - Results from a phase 1 project in the Wheatbelt Region - Christine Henneker

• Tools at hand-Educational standardisation - Olayinka O Akinsanmi
• Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost - Vikneswary Batumalai
• Introduction of a speech pathology assistant role for swallow screening in a head and neck radiotherapy clinic - Jacqui Frowen
• Reducing the cancer malnutrition burden: highlights of state-wide collaborations in Victorian health services - Jenelle Loeliger
• Risk of emergency hospitalisation following adjuvant chemotherapy for early breast cancer in NSW - Hanna E Tervonen

• Improving the clinical practice for fertility preservation - Natalie Bradford
• Staging scans (SS) in pre-operative, asymptomatic, stage I/II early breast cancer (EBC) patients (pts) at Bankstown-Lidcombe Hospital - Abhijit Pal
• Improving medication labelling – patients driving their information - Janelle Penno
• Using data to drive change.  Evaluation of Cancer Outcomes Barwon South West (ECOBSW) Registry - Graham Pitson
• Assessing ovarian cancer care in Victoria against the optimal care pathway - Carmel Vermeltfoort

• Oral cancer treatment: Making it safe - Monika Krzyzanowska
• Dosing considerations with oral cancer treatments - Howard Gurney
• Oral cancer treatments: Drug interactions & other challenges - Gail Rowan
• Rapid-assessment nurse clinic: exploring reasons for ED presentation during oral cancer treatment - Polly H Dufton
• Closing the gap: Educating community pharmacists on oral antineoplastic treatments - Aisling Kelly

• Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography - Gemma Jacklyn
• Sexual behaviour, HPV status and p16 expression in oropharyngeal and oral cavity squamous cell carcinoma patients - Annika Antonsson
• Patterns of care and outcomes for long-term survivors with HER2-positive metastatic breast cancer (HER2+MBC) starting trastuzumab: an Australian whole-of-population cohort study - Benjamin Daniels
• Higher comorbidity burden does not explain lower survival for Indigenous Australian women with cervical cancer - Abbey Diaz
• Premenopausal and postmenopausal breast cancer burden attributable to health behaviours and hormonal factors - Maarit A Laaksonen

• Enhancing regional cancer services across Australia to improve outcomes for rural and regional cancer patients - Susan Hanson
• Improving radiotherapy quality through collaboration - Colin Hornby
• Population-Based Analysis of Radiotherapy and Chemotherapy Treatment in the Last Month of Life - Graham Pitson
• Doing better at ‘Difficult Discussions’: Australian Oncology Professionals’ perspectives on End-of-Life communication with adolescents and young adults with cancer - Ursula M Sansom-Daly
• Cancer research participation by culturally and linguistically diverse (CALD) patients in South Western Sydney from 2006 - 2016: A retrospective analysis - Ben Smith

• Money matters: the effects of financial toxicity on treatment compliance - Kim Hobbs
• Social determinants of treatment adherence. - Tish Lancaster
• Even checked baggage flies with us: We can't escape our past experiences when confronted by cancer - Jane Turner
• “Like approaching the edge of a cliff” … How mood, fear, and beliefs affect adherence - Maree Grier

• Exercise and Immunotherapy  - Michael Marthick
• The intestinal microbiome, chemotherapy and adjuvant treatments with probiotics. - Luis Vitetta
• An integrative model of wellness & supportive care - Penelope Sanderson
•  Supportive and palliative care - Judith Lacey
• Living well with immunotherapies - the patient perspective - Karen van Gorp

Tom Reeve Oration